Loeb Partners Corp’s Celgene Corp CELG Stock Holding History

Loeb Partners Corp’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$18K	–	154
2019 Q1	$18K	Sell	200 -425	-68%	-$37.2K	0.37%	64
2018 Q4	$169K	Sell	625 -2,565	-80%	-$189K	0.08%	125
2018 Q3	$283K	Sell	3,190 -3,500	-52%	-$309K	0.1%	125
2018 Q2	$532K	Buy	6,690 +2,360	+55%	+$196K	0.13%	120
2018 Q1	$387K	Buy	+4,330	New	+$416K	0.17%	96
2017 Q1	–	Sell	-7,000	Closed	-$810K	–	175
2016 Q4	$810K	Hold	7,000	–	–	0.27%	81
2016 Q3	$732K	Buy	7,000 +750	+12%	+$81.2K	0.26%	86
2016 Q2	$616K	Buy	6,250 +3,000	+92%	+$310K	0.2%	93
2016 Q1	$325K	Hold	3,250	–	–	0.12%	119
2015 Q4	$389K	Buy	+3,250	New	+$376K	0.12%	118

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Loeb Partners Corp's CELG Position: Q2 2019 in Review

Loeb Partners Corp sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 200 shares — an estimated $18K sold.

Loeb Partners Corp first reported a position in CELG in Q4 2015 and held it in 10 quarters. The position peaked at $810K in Q4 2016. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Loeb Partners Corp reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Loeb Partners Corp sold 200 Celgene Corp shares in Q2 2019, an estimated $18K.
Loeb Partners Corp first reported a position in Celgene Corp in Q4 2015 and held it in 10 quarters.
Loeb Partners Corp's Celgene Corp position peaked at $810K in Q4 2016.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Loeb Partners Corp's 13F filing for Q2 2019.